drugset / Trial / NCT00152256
A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids
RandomizedParallel-groupTriple-blindTreatment
Summary
The objective of this study is to determine the safety and efficacy effects of two doses of asoprisnil (10 mg and 25 mg) compared with placebo when administered daily for 6 months to premenopausal subjects with symptomatic uterine leiomyomata.
Timeline
- Start
- 2003-09
- Primary completion
- 2005-02
- Completion
- 2005-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asoprisnil | Other / unclassified | 10 mg | Oral |
| Subject | Asoprisnil | Other / unclassified | 25 mg | Oral |